Bora Pharmaceuticals Co., LTD. (TPE:6472)

TPE:6472 Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	5,829	3,053	3,281	910.75	669.99
Short-Term Investments	67.86	342.63	247.62	-	-
Trading Asset Securities	20.28	-	-	-	-
Cash & Short-Term Investments	5,917	3,396	3,529	910.75	669.99
Cash Growth	74.25%	-3.77%	287.48%	35.94%	23.46%
Accounts Receivable	10,482	4,028	6,120	824.77	539.63
Other Receivables	954.57	82.61	286.38	33.23	186.77
Receivables	11,436	4,111	6,407	858.01	726.4
Inventory	5,502	2,157	1,991	928.64	1,112
Prepaid Expenses	591	801.43	242.47	63.07	51.33
Other Current Assets	118.63	138.63	71.58	31.87	67.01
Total Current Assets	23,566	10,604	12,241	2,792	2,627
Property, Plant & Equipment	12,510	7,494	7,300	4,067	4,158
Long-Term Investments	236.33	21.26	62.03	-	-
Goodwill	3,664	3,010	983.59	-	-
Other Intangible Assets	3,780	2,665	1,164	171.05	4.93
Long-Term Deferred Tax Assets	1,190	1,045	829.64	243.78	37.09
Other Long-Term Assets	652.74	294.85	181.01	98.65	177.22
Total Assets	45,599	25,134	22,761	7,372	7,004
Accounts Payable	792.34	380.45	454.74	235.81	219.06
Accrued Expenses	132.63	30.86	29.33	321.24	217.8
Short-Term Debt	2,598	767.51	2,161	645.48	1,218
Current Portion of Long-Term Debt	1,189	630.5	725.63	222.09	161.65
Current Portion of Leases	116.6	106.04	75.31	17.54	18.68
Current Income Taxes Payable	484.33	987.43	238.65	50.58	18.35
Current Unearned Revenue	245.6	224.6	85.69	20.47	4.11
Other Current Liabilities	8,250	5,102	6,725	327.91	428.77
Total Current Liabilities	13,809	8,229	10,496	1,841	2,286
Long-Term Debt	14,324	2,724	4,037	1,028	1,158
Long-Term Leases	745.96	763.33	596.88	305.97	325.37
Long-Term Unearned Revenue	-	-	4.18	-	-
Long-Term Deferred Tax Liabilities	1,256	783.9	742.85	609.77	202.01
Other Long-Term Liabilities	323.59	753.09	1,608	298.57	413.15
Total Liabilities	30,587	13,368	17,621	4,220	4,539
Common Stock	1,031	1,014	753.82	684.12	541.15
Additional Paid-In Capital	4,408	3,318	1,236	1,026	951.65
Retained Earnings	7,107	4,729	2,549	1,466	961.01
Treasury Stock	-43.18	-50.97	-53.09	-	-
Comprehensive Income & Other	364.58	74.66	42.2	-23.26	10.95
Total Common Equity	12,867	9,085	4,528	3,153	2,465
Minority Interest	2,144	2,681	612.13	-	-
Shareholders' Equity	15,012	11,766	5,140	3,153	2,465
Total Liabilities & Equity	45,599	25,134	22,761	7,372	7,004
Total Debt	18,973	4,991	7,596	2,219	2,881
Net Cash (Debt)	-13,056	-1,595	-4,067	-1,308	-2,211
Net Cash Per Share	-116.55	-15.40	-41.20	-13.44	-22.91
Filing Date Shares Outstanding	102.84	101.12	97.52	97.78	96.42
Total Common Shares Outstanding	102.84	101.12	97.52	97.78	96.42
Working Capital	9,757	2,375	1,745	951.22	340.48
Book Value Per Share	125.12	89.84	46.43	32.24	25.56
Tangible Book Value	5,423	3,410	2,381	2,981	2,460
Tangible Book Value Per Share	52.73	33.72	24.41	30.49	25.51
Land	3,824	3,424	3,397	1,984	2,021
Buildings	7,963	1,945	1,905	1,393	1,329
Machinery	6,113	2,814	2,390	859.79	838.14
Construction In Progress	527.38	115.84	76.72	11.73	-
Leasehold Improvements	-	-	205.29	-	8.1

Source: S&P Global Market Intelligence. Standard template. Financial Sources.